An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 021248
Company: CEPHALON

Products on NDA 021248

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
TRISENOX	ARSENIC TRIOXIDE	1MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE;INJECTION	Discontinued	None	Yes	No
TRISENOX	ARSENIC TRIOXIDE	2MG/ML	INJECTABLE;INJECTION	Prescription	AP	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 021248

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
09/25/2000	ORIG-1	Approval	Type 1 - New Molecular Entity	PRIORITY; Orphan	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21248lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/21248ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/21-248_Trisenox.cfm

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
10/20/2020	SUPPL-19	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021248s019lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/021248Orig1s019ltr.pdf
06/20/2019	SUPPL-18	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021248s018lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021248Orig1s018ltr.pdf
01/12/2018	SUPPL-15	Efficacy-New Indication	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021248s015lbledt.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/021248Orig1s015ltr.pdf
02/20/2015	SUPPL-13	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021248s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021248Orig1s013ltr.pdf
07/23/2010	SUPPL-9	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021248s008s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021248s008,s009ltr.pdf
07/23/2010	SUPPL-8	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021248s008s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021248s008,s009ltr.pdf
01/07/2003	SUPPL-2	Manufacturing (CMC)		Label is not available on this site.
06/13/2001	SUPPL-1	Manufacturing (CMC)-Expiration Date		Label is not available on this site.

Labels for NDA 021248

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
10/20/2020	SUPPL-19	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021248s019lbl.pdf
06/20/2019	SUPPL-18	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021248s018lbl.pdf
01/12/2018	SUPPL-15	Efficacy-New Indication	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021248s015lbledt.pdf
02/20/2015	SUPPL-13	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021248s013lbl.pdf
07/23/2010	SUPPL-9	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021248s008s009lbl.pdf
07/23/2010	SUPPL-8	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021248s008s009lbl.pdf
09/25/2000	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21248lbl.pdf

Therapeutic Equivalents for NDA 021248

TRISENOX

INJECTABLE;INJECTION; 2MG/ML
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ARSENIC TRIOXIDE	ARSENIC TRIOXIDE	2MG/ML	INJECTABLE;INJECTION	Prescription	No	AP	210739	AMNEAL
ARSENIC TRIOXIDE	ARSENIC TRIOXIDE	2MG/ML	INJECTABLE;INJECTION	Prescription	No	AP	214011	EUGIA PHARMA
ARSENIC TRIOXIDE	ARSENIC TRIOXIDE	2MG/ML	INJECTABLE;INJECTION	Prescription	No	AP	215059	GLAND PHARMA LTD
ARSENIC TRIOXIDE	ARSENIC TRIOXIDE	2MG/ML	INJECTABLE;INJECTION	Prescription	No	AP	217413	ORBICULAR
ARSENIC TRIOXIDE	ARSENIC TRIOXIDE	2MG/ML	INJECTABLE;INJECTION	Prescription	No	AP	215359	SANDOZ
ARSENIC TRIOXIDE	ARSENIC TRIOXIDE	2MG/ML	INJECTABLE;INJECTION	Prescription	No	AP	206228	ZYDUS PHARMS
TRISENOX	ARSENIC TRIOXIDE	2MG/ML	INJECTABLE;INJECTION	Prescription	Yes	AP	021248	CEPHALON

Top